Page 22 - Securities Note News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  IMPORTANT: The following disclaimer applies to the Supplement available by clicking on the link above, and you are therefore advised to read this disclaimer carefully before reading, accessing or making any other use of the Supplement or any Base Prospectus or Registration Document to which the Supplement relates. NEITHER THE SUPPLEMENT NOR ANY BASE PROSPECTUS OR REGISTRATION DOCUMENT MAY BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE SUPPLEMENT AND THE BASE PROSPECTUSES OR REGISTRATION DOCUMENT MA...

  IMPORTANT: The following disclaimer applies to the Supplement available by clicking on the link above, and you are therefore advised to read this disclaimer carefully before reading, accessing or making any other use of the Supplement or any Base Prospectus or Registration Document to which the Supplement relates. NEITHER THE SUPPLEMENT NOR ANY BASE PROSPECTUS OR REGISTRATION DOCUMENT MAY BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE SUPPLEMENT AND THE BASE PROSPECTUSES OR REGISTRATION DOCUMENT MA...

Search jobs 09-Feb-2021 Genomic Vision Announces the Availability of the Prospectus Relating to the Financing Program Concluded With Winance for a Maximum Amount of €12 Million BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: Genomic Vision (Paris:GV) (the “Company” - FR0011799907 - GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announces the availability of the prospectus relating to the financing program concluded with Winance in form of convertible notes...

Aker ASA: Approval of prospectus OSLO, Norway, Feb. 4, 2021 /PRNewswire/ -- The Financial Supervisory Authority of Norway has on 3 February 2021 approved Supplement number 1 to the Base Prospectus dated 13 February 2020. The Supplement number 1 has been prepared in connection with the Additional Bonds (tap issue) of AKER15 (ISIN NO0010868979) of NOK 500,000,000 as announced 20 January 2021. The Base Prospectus dated 13 2020, Supplement number 1 dated 3 February 2021 and Securities Note dated 3 February 2021 constitute a Prospectus, covering the listing of the Additional Bonds on Oslo Børs. ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...